Literature DB >> 2836611

A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.

J M Hardwick1, P M Lieberman, S D Hayward.   

Abstract

Several Epstein-Barr virus (EBV) early promoters respond to a new EBV transactivator encoded by BRLF1, designated R. Transactivation was measured in chloramphenicol acetyltransferase assays on Raji, BHK, and Vero cells that were cotransfected with the transactivator and target promoters linked to the cat gene. The divergent promoter of BamHI-H was particularly responsive to R transactivation. This large promoter region consists of a leftward TATA box for the NotI repeat gene (BHLF1) and a probable rightward TATA box for the EA-R gene (BHRF1) separated by 940 base pairs of unusual sequence complexity. Sequences within this divergent promoter region appear to confer inducibility by EBV transactivators R and Z (BZLF1). The Z transactivator stimulated expression in both the leftward and rightward directions, and R stimulated expression primarily in the rightward direction, but the MS transactivator (BMLF1) had no activity in either direction. The adenovirus E3 promoter also responded to the R transactivator, but several other herpesvirus and human promoters were nonresponsive. When the divergent promoter was linked to the EA-R gene as it is in the EBV genome, the R and Z transactivators also induced the expression of EA-R in cotransfected cells. This cytoplasmic early antigen is encoded by BHRF1 and may be anchored in intracellular membranes by a carboxy-terminal transmembrane region.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836611      PMCID: PMC253372          DOI: 10.1128/JVI.62.7.2274-2284.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.

Authors:  G R Pearson; J Luka; L Petti; J Sample; M Birkenbach; D Braun; E Kieff
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

2.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

Review 3.  Mechanisms of protein localization.

Authors:  T J Silhavy; S A Benson; S D Emr
Journal:  Microbiol Rev       Date:  1983-09

4.  Organization of the Epstein-Barr virus DNA molecule. II. Fine mapping of the boundaries of the internal repeat cluster of B95-8 and identification of additional small tandem repeats adjacent to the HR-1 deletion.

Authors:  S D Hayward; S G Lazarowitz; G S Hayward
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

Review 5.  Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma.

Authors:  K Nilsson; G Klein
Journal:  Adv Cancer Res       Date:  1982       Impact factor: 6.242

6.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

7.  A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates.

Authors:  A Polack; G Hartl; U Zimber; U K Freese; G Laux; K Takaki; B Hohn; L Gissmann; G W Bornkamm
Journal:  Gene       Date:  1984-03       Impact factor: 3.688

8.  Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not to the cell surface.

Authors:  J L Guan; J K Rose
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

9.  E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.

Authors:  D L Weeks; N C Jones
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  168 in total

1.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Mechanism for specificity by HMG-1 in enhanceosome assembly.

Authors:  K B Ellwood; Y M Yen; R C Johnson; M Carey
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.

Authors:  K Ellwood; W Huang; R Johnson; M Carey
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 5.  The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  Mol Pathol       Date:  2000-10

6.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.

Authors:  C D Darr; A Mauser; S Kenney
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Inhibition of gammaherpesvirus replication by RNA interference.

Authors:  Qingmei Jia; Ren Sun
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

9.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

10.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.